Spinal muscular atrophy: molecular genetics and diagnostics

Area of Science:

• Genetics
• Neurology
• Molecular Biology

Background:

• Spinal muscular atrophy (SMA) is a frequent autosomal recessive disorder affecting 1 in 10,000 live births.
• It stems from a deficiency in the survival of motor neuron (SMN) protein, crucial for neuronal function.
• SMN protein is encoded by SMN1 and SMN2 genes, with SMN2 producing less functional protein.

Purpose of the Study:

• To summarize the genetic basis of Spinal Muscular Atrophy (SMA).
• To highlight the importance of genetic testing and counseling for SMA.
• To discuss current and future diagnostic technologies for SMA.

Main Methods:

• Review of genetic mechanisms underlying SMA.
• Analysis of diagnostic techniques including PCR-restriction fragment length polymorphism and SMN gene dosage analysis.
• Discussion of animal models for SMA research.

Main Results:

• PCR-RFLP assays detect homozygous SMN1 absence in 94% of typical SMA patients.
• SMN gene dosage analysis identifies carriers and heterozygotes.
• Current genetic testing combined with counseling offers comprehensive evaluation.

Conclusions:

• Accurate risk assessment and genetic counseling are vital due to SMA's genetic complexity and high carrier frequency.
• Comprehensive SMA genetic testing is the current standard for patient and family evaluation.
• Emerging technologies like monosomal analysis may enhance future diagnostic capabilities.